OZEM Company Profile and Key Details

Roundhill Investments - GLP-1 & Weight Loss ETF (NASDAQ:OZEM) closed at $31.45 USD, losing -$0.52 (-1.63%) from the previous close of $31.97. The stock is currently mid-range between its 52-week high and low $25.66 and $37.15. With a market capitalization of about $40.42 million, Roundhill Investments - GLP-1 & Weight Loss ETF is classified as a micro-cap and shows lower-than-market volatility (beta ~0.43). Key stats such as the average daily volume over the past year has been around 21.93 thousand shares, volume is running light vs its 52-week average. Headquartered in New York, NY, Roundhill Investments - GLP-1 & Weight Loss ETF operates in the Financial Services sector and the Asset Management industry. Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape.

Short-term trend indicators are mixed aligned (SMA20 -4.77%, SMA50 -5.11%, SMA200 14.32%). The stock’s 14-day RSI is 34.24 (weak momentum), while the ATR of 0.64 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -10.05% below its high and over 66.99% above its low. Average 10-day trading volume of 24.11 thousand shares is slightly above the 3-month average of 21.55 thousand, indicating heightened recent market interest.

Roundhill Investments - GLP-1 & Weight Loss ETF last paid a dividend of 0.41 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Our AI price prediction model suggests that Roundhill Investments - GLP-1 & Weight Loss ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.